Journal Article

Roadmap for HCC Surveillance and Management in the Asia Pacific

Kim, Do Young, Bunnag, Sakarn, Kudo, Masatoshi, Chen, Chien-Jen, Kanto, Tatsuya, Sarno, Roberta, Ngat, Do Thi, Tangkijvanich, Pisit, Oanh, Bui Thi, Lu, Sheng-Nan, George, Jacob, Piratvisuth, Teerha, Pimsawadi, Luckxawan, Mohamed, Rosmawati, Kudtiyakarn, Sirintip, Pwu, Raoh-Fang, Wu, Chao-Chun

2025

Overview

Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with the Asia-Pacific (APAC) region bearing a disproportionate burden. This paper examines HCC challenges within seven APAC health systems, identifies key barriers at each stage of the patient journey, and proposes tailored, actionable solutions. To effectively address HCC challenges, a stepwise approach should prioritise high-impact solutions, focusing on prevention, early diagnosis, and expanding surveillance to maximise health outcomes and economic benefits, while tailoring strategies to each health system’s unique resources and constraints. Methods: A mixed-methods approach was used, including expert consultations from the 2024 HCC APAC Policy Forum, a literature review, and a review of Japan’s HCC management model. Data were collected through workshops and stakeholder feedback from healthcare professionals, policymakers, researchers and patient advocates across Australia, India, Malaysia, South Korea, Taiwan, Thailand, and Vietnam. Results: Key findings include significant disparities in HCC awareness, prevention, early detection, diagnosis, and access to treatment. Common challenges across APAC include limited public awareness, suboptimal surveillance infrastructure, and financial barriers to care. The integration of novel biomarkers and advanced surveillance modalities were identified as crucial priorities for improving early detection. Japan’s multi-faceted approach to HCC management serves as a successful model for the region. Conclusions: A customised and targeted approach is essential for reducing the HCC burden across APAC. The proposed recommendations, tailored to each health system’s needs, can significantly improve patient outcomes and reduce healthcare costs. Effective collaboration among stakeholders is necessary to drive these changes.

• Publisher: MDPI AG,MDPI
• Subject: Analysis / Cancer / Cholangitis / Clinical outcomes / Collaboration / Demographic aspects / Diabetes / Diagnosis / Disease prevention / Epidemiology / Evidence-based medicine / Health aspects / Health care / Hepatitis B / Hepatitis C / Hepatocellular carcinoma / Hepatoma / Life style / Literature reviews / Liver / Liver cancer / Liver diseases / Metabolism / Methods / Mortality / Obesity / Oncology, Experimental / Patient compliance / Patients / Prevalence studies (Epidemiology) / Public health / Quality of life / Reimbursement / Risk factors / Stakeholders / Surveillance / Type 2 diabetes / Workshops